Catalyst Wire Dossier Catalyst Wire Dossier

Farydak

panobinostat · Novartis
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Farydak, covering 2012-03-20 to 2025-10-01. Get the full timeline:

Most recent: EMA Authorised: Farydak (panobinostat lactate anhydrous) — pharmaand GmbH

See pricing